Virios Therapeutics, Inc. (VIRI)

NASDAQ: VIRI · IEX Real-Time Price · USD

0.234

+0.012 (5.41%)

At close: Jul 2, 2024, 4:00 PM

0.237

+0.003 (1.28%)

After-hours: Jul 2, 2024, 7:56 PM EDT

Virios Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	6	11	4	43	59	-
Market Cap Growth	36.96%	155.97%	-89.85%	-27.56%	-	-
Enterprise Value	4	8	-3	29	29	3
PE Ratio	-	-2.09	-0.35	-2.67	-5.68	-
PB Ratio	2.45	2.91	0.59	2.94	1.97	-
P/FCF Ratio	-2.25	-2.27	-0.38	-2.72	-15.10	-
P/OCF Ratio	-2.25	-2.27	-0.38	-2.72	-15.10	-
EV/EBITDA Ratio	-1.35	-1.46	0.22	-1.79	-2.91	-1.53
EV/EBIT Ratio	-1.35	-1.46	0.22	-1.79	-2.91	-1.53
EV/FCF Ratio	-1.67	-1.59	0.24	-1.82	-7.45	-1.59
Debt / Equity Ratio	-	-	-	-	-	-0.72
Debt / EBITDA Ratio	-	-	-	-	-	-1.67
Debt / FCF Ratio	-	-	-	-	-	-1.74
Quick Ratio	4.17	9.25	6.74	10.98	19.45	0.19
Current Ratio	5.66	11.62	8.02	12.37	20.55	0.20
Interest Coverage	-	-	-	-	-25.93	-7.38
Return on Equity (ROE)	-127.40%	-110.10%	-142.60%	-76.60%	-83.00%	65.40%
Return on Assets (ROA)	-113.60%	-100.20%	-120.00%	-72.60%	-65.10%	-1295.70%
Return on Capital (ROIC)	-196.03%	-143.08%	-168.09%	-107.86%	-33.42%	157.87%
Earnings Yield	-78.06%	-47.83%	-283.12%	-37.46%	-17.59%	-
FCF Yield	-63.27%	-43.98%	-265.09%	-36.82%	-6.62%	-
Buyback Yield / Dilution	-5.06%	-69.62%	-32.91%	-69.05%	-1.96%	-
Total Shareholder Return	-5.06%	-69.62%	-32.91%	-69.05%	-1.96%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).